Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2019
Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic CancerAndrew J AguirreCold Spring Harbor Perspectives in Medicine|November 5, 2017
Synthetic Lethal Vulnerabilities in <i>KRAS</i>-Mutant CancersAndrew J Aguirre, William C HahnCancer Journal (Sudbury, Mass.)|December 1, 2017
Advances in the Genetics and Biology of Pancreatic CancerAndrew J Aguirre, Eric A CollissonCancer Cell|September 13, 2022
Getting a handle on KRAS inhibitor resistance with hapten-mediated anti-tumor immunityWilliam A Freed-Pastor, Andrew J AguirreCancer Research|September 16, 2024
Hope on the Horizon: A Revolution in KRAS Inhibition Is Creating a New Treatment Paradigm for Patients with Pancreatic CancerAndrew J Aguirre, Ben Z Stanger, Anirban MaitraJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2021
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic CancerHarshabad Singh, Kimberly Perez, Brian M Wolpin, et al.Cancer Discovery|April 28, 2025
Response and Resistance to RAS Inhibition in CancerRichard Y Ebright, Julien Dilly, Alice T Shaw, et al.Nature Cancer|March 30, 2022
Translational advances in pancreatic ductal adenocarcinoma therapyAbdel Nasser Hosein, Stephanie K Dougan, Andrew J Aguirre, et al.Molecular Cell|May 28, 2020
Biomarker-Guided Development of DNA Repair InhibitorsJames M Cleary, Andrew J Aguirre, Geoffrey I Shapiro, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 23, 2024
Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic CancerRachael A Safyan, Eejung Kim, Emmelie Dekker, et al.Pageof 12